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Introduction
Computed tomography (CT) imaging has been well esta-
blished within the radiotherapy treatment planning pro-
cess for several years. Magnetic resonance imaging (MRI)
is not currently used as extensively as CT but is continu-
ously gaining in importance [1-6]. This advance in the
use of MRI is due to the advantage over CT imaging of
better tumour delineation in the different planes of inte-
rest required for treatment planning: coronal, lateral and
sagittal.
Early proposals for MRI clinical applications in ra-
diation therapy planning have been published by several
groups during the period 1985-2002 [6-23]. However, the
applications concentrated mainly on imaging of the brain
and CNS, with a recent application for infra-diaphrag-
matic lymph nodes [21]. Extension to regions other than
the brain is not very common and this is possibly due to
the absence of computer software and application techni-
que for integrating MRI into the overall computer treat-
ment planning process.
This paper describes the Kiel University method of
integrating MRI with simulator fluoroscopic images using
modern computer technology, in order to provide im-
proved definition of the target volume.
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I n t r o d u c t i o n.  The aim of this paper is to demonstrate the advantages of MRI over CT in the field of radiotherapy
treatment planning: particularly for tumour delineation in coronal, lateral and sagittal planes.
M e t h o d s  a n d  m a t e r i a l.  Technical requirements necessary are a (1) conventional therapy simulator capable of
producing digital image data, and (2) an MRI system where the digital image data can be used within a data network
system. Image data from the simulator fluoroscopy mode and the MRI data are transferred to a Macintosh PC system.
Data is transferred via Ethernet to the treatment planning system. Image enhancement is performed. 240 patients have been
planned using the technique.
R e s u l t s.  Results in terms of spatial deviations are described for target volumes in liver, spleen, and pelvic regions and also
for brain tumours. Results are shown for two patients (1) with Hodgkin's disease, and (2) with a pinealis gland tumour.
C o n c l u s i o n s.  The technique is an important supplement to existing technologies. It is inexpensive and cost-effective
and is an advance on conventional simulation techniques.
Planowanie radioterapii z zastosowaniem techniki rezonansu magnetycznego
W s t ´ p.  Celem pracy jest wykazanie zalet rezonansu magnetycznego w stosunku do tomografii komputerowej w planowaniu
leczenia radioterapià, w szczegónoÊci w zakresie oznaczenia granic guza w poszczególnych p∏aszczyznach.
M a t e r i a ∏  i m e t o d y.  Niezb´dny sprz´t obejmuje konwencjonalny sumulator zdolny do przedstawienia danych w posatci
cyfrowej oraz aparat do magnetycznego rezonansu jàdrowego, która umo˝liwia przetwarzanie danych cyfrowych w obr´bie sieci.
Dane fluoroskopowe uzyskane z symulatora i dane z magnetycznego rezonansu jàdrowego sà opracowywane za pomocà
systemów Macintosh, a nastepnie przekazywane za pomocà Etherent do uk∏adu planujàcego leczenie, gdzie opracowuje si´
obraz. Jak dotychczas metod´ t´ zastosowano w leczeniu 240 chorych.
W y n i k i.  Wyniki zosta∏y opisane jako dawki na obszary referencyjne w obr´bie wàtroby, Êledziony i miednicy, jak równie˝ na
obszar mózgu. Zosta∏y one przedstawione dla wdóch pacjentów – jednego z chorobà Hodgkina i jednego z guzem szyszynki.
W n i o s k i.  Technika ta stanowi istotne uzupelnienie stosowanych obecnie metod. Jest to metoda ma∏o kosztowna i efektywna,
stanowiàca post´p w stosunku do konwencjonalnych technik symulacji.
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Our main imaging tool for tumour staging and for tumour volu-
me definition in treatment planning is CT with secondary in-
put using fluoroscopy and radiography. For example, in the case
of infra-diaphragmatic lymph nodes for patients with Hodg-
kin's lymphoma, we perform urography with radiographs to assist
in defining the field margins required to cover the target volume.
The topographic orientation of the fields and target volume are
defined using CT and ultrasound imaging as well as the results of
the urogram. These images enable construction of individual
shielding within a treatment field for each patient. Then, the
MRI is performed.
The primary technical requirement for MRI based treat-
ment planning is a conventional therapy simulator capable of
producing digital image data. Such image data can be obtained
using radiographic film when can then be digitised using a film
scanner and the data transferred to the treatment planning sys-
tem via a personal computer [PC].
The secondary technical requirement is the availability of
an MRI system whose digital image data can be used within
a data network system. An alternative to this requirement is to
store the data on a removable hard disc, for example a SyQuest
44 MB cartridge.
At Kiel, the image data from the simulator fluoroscopy
mode and the MRI data are transferred on a network to an Ap-
ple Macintosh Performa PC system with a 5260 MB hard disc
and 120 MB RAM. The treatment planning procedures involving
the images can then take place.
After defining the target volume, conventional simulation
is performed and the treatment fields are documented on film.
MRI is then performed in the required plane(s) as defined in the
pre-planning process and T1 weighted (415/25) spin echo (SE)
sequences are obtained with the optional use of Gadolinium-
-DTPA. Digitised simulator fluoroscopic and MRI data are
transferred on line via Ethernet to the computer treatment plan-
ning system.
The images are enhanced using our Kiel developed Gyro-
plan software [22,24] and for example the fluoroscopic image is
edge-traced. In the MRI the tumour, critical organs or a pre-
-planned target volume are marked with a cursor. Then the flu-
oroscopic and MR images are merged and superimposed, being
first oriented using anatomical landmarks. These landmarks are
usually bony structures such as the skull for brain tumours, spi-
ne and ribs for thoracic tumours and spine and hips for pelvic tu-
mours. Usually an MRI plane we select contains the maximum
extension of the tumour. At this stage we correct the MRI data
set by an appropriate scaling factor: otherwise merging with the
fluoroscopic image would not be correctly achieved.
The result is an integrated display of bony structures from
fluoroscopy and of soft tissue structures from MRI. This enables
an improved assessment of field margins and also permits, if
necessary, reconsideration of the radiation therapy technique.
These results are documented via a video link which has connec-
ted a laser printer and a multi-format camera in order to obtain
hardcopy outputs: see Figure 1.
Technically introduced image distortions have been stu-
died [25-27]. Phantom measurements revealed that the MR
image distortion due to magnetic field lines and a possible diver-
gence fault are negligible in clinical practice. We use a six minu-
te standard MRI sequence which is optimal considering a bre-
athing sequence. We have also used phantom measurements to
compare the positional accuracy of the fluoroscopic and MR
images and found a maximum deviation of only 2 mm at distan-
ces greater than 20 cm from the isocentre.
We have planned 240 consecutive patients using the above
described technique for the following treatment sites for pri-
mary or metastatic disease: 56 abdomen and spleen, 54 pelvis, 37
thoracic, 37 brain, 36 head and neck and 20 liver.
Results
Our study showed that major deviations occurred in the
target volumes for liver and spleen tumours. Previously
for a liver target volume ultrasound imaging was perfor-
med and this for example was found to be inadequate. In
13/20 patients the caudal liver margin was inaccurate by
3-6 cm. Due to this inaccuracy, without MRI, significant
portions of the small bowel would have been irradiated
due to its proximity to the caudal and medial liver mar-
gins.
For the spleen similar problems were observed and
an accurate target volume was obtained using ultrasound
in only 21/56 patients. In 35/56 patients errors of 1.0-4.5
cm were noted. In particular, the size of the splenic me-
dial upper volume was rarely defined correctly and the
caudal volume was often defined using ultrasound ima-
ging as too large and therefore caused uneccessary over-
lap with the left kidney: see Figure 2.
In the pelvic region for 22/54 patients the deviations
were 2-4 cm between CT and MR imaging methods but
Figure 1. Flow chart for the primary digital framework of the method
Table I. Patients requiring target volume modifications
after assessment using MRI
Tumour site No. patients No. requiring
a modification
Brain 37 7
Head & neck 36 5
Thorax 37 4
Liver 20 13
Abdomen & spleen 56 35
Pelvis 54 22
All sites 240 86
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this was in part due to organ motion in this area. Howe-
ver, when compared to urogram results those with MRI
differed by only 1 cm although the quality of the image
was improved when using MRI.
Our new planning technique involving the use of
MRI was also an advantage for treating brain tumours
following resection of the primary lesion. The sagittal
MR images acquired prior to neurosurgery were superim-
posed on the lateral brain simulator fluoroscopic images
in order to optimally view the primary tumour site. Diffe-
rences between conventionally simulated teletherapy be-
ams compared to those defined using MRI could be as
large as 2.5 cm. Thus although the target volumes were
never underdosed, it led to larger than necessary boost
doses being applied. With MRI the target volume could
be reduced: see Figure 3.
Figure 2a Figure 3a
Figure 2b Figure 3b
Figure 2c
Figure 2. 35-year old male with Hodgkin's disease. [a] Simulation of
AP/PA opposing fields and with the use of contrast media. [b] Coronal
spin echo T1-weighted MR image with the spleen delineated [by
a white jagged outline]. [c] Superimposition of both images showing
the soft tissue and the spleen fully covered by the radiation fields. The
left kidney is also shown to be shielded.
Figure 3c
Figure 3. Imaging of pinealis gland tumour in an 11-year old boy. [a]
Simulator image with lateral opposing fields. [b] Sagittal spin echo T1-
-weighted MR image with the tumour volume delineated. [c] Superim-
position of both images adapted in terms of image size and position.
Note that the preplanned radiation beam fully covers the tumour volu-
me.
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Table I gives the frequency of target volume modifi-
cations required for our series of 240 patients and it is se-
en that overall, there is a significantly large figure of 36%
[86/240] who required modifications.
Discussion
Using MR imaging-based radiotherapy treatment plan-
ning by digital image superimposition a significant im-
provement can be made in the accuracy of definition of
target volumes: particularly for liver and spleen volumes.
Individual shielding of critical volumes in the liver and pe-
lvic regions can also be improved using this technique.
Our study has also shown that target volumes can
be reduced, sometimes remarkably so, and this obviously
relates to the possibility of short-term and long-term side
effects to organs such as the small bowel and kidneys.
Since only a PC and digitised data are necessary this
is cost-effective treatment planning technology. Howe-
ver, special software such as Gyroplan [24] is desirable to
maximise image manipulation possibilities.
Conclusions
The technique using MRI which has been developed at
Kiel University is an important supplement to existing
methodologies [28] and permits the radiation oncologist
to use MRI to its best advantage [29]. Since the technolo-
gy only requires a data network between simulator, MR
scanner and PC for quick and easy application of the me-
thod, it can be performed in many existing centres. It is
hoped that this advance in treatment planning will lead to
improved tumour control and increased survival.
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